# FMC Corp: Form 10-Q for the period ended Jun 30, 2013

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2013-07-30
- Accepted by EDGAR: Jul 30, 2013, 18:04 ET
- Period: 2013-06-30
- Accession: 0000037785-13-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778513000032/fmc630201310q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778513000032/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-04-01 to 2013-06-30 | $959.4m | us-gaap:Revenues |
| Revenue | 6 months, 2013-01-01 to 2013-06-30 | $1.95bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-04-01 to 2013-06-30 | $616.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2013-01-01 to 2013-06-30 | $1.24bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2013-04-01 to 2013-06-30 | $342.9m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2013-01-01 to 2013-06-30 | $712.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2013-04-01 to 2013-06-30 | $138.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2013-01-01 to 2013-06-30 | $270.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-04-01 to 2013-06-30 | $168.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2013-01-01 to 2013-06-30 | $367.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-04-01 to 2013-06-30 | $36.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2013-01-01 to 2013-06-30 | $84.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-04-01 to 2013-06-30 | $118.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2013-01-01 to 2013-06-30 | $248.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-04-01 to 2013-06-30 | $0.86 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2013-01-01 to 2013-06-30 | $1.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-04-01 to 2013-06-30 | $0.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2013-01-01 to 2013-06-30 | $1.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-04-01 to 2013-06-30 | 137,141,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2013-01-01 to 2013-06-30 | 137,736,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2013-01-01 to 2013-06-30 | $245.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2013-01-01 to 2013-06-30 | $96.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2013-01-01 to 2013-06-30 | $37.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2013-01-01 to 2013-06-30 | $109.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-06-30 | $77.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-06-30 | $2.18bn | us-gaap:AssetsCurrent |
| Total assets | at 2013-06-30 | $4.35bn | us-gaap:Assets |
| Current liabilities | at 2013-06-30 | $1.27bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2013-06-30 | $762.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2013-06-30 | $21.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2013-06-30 | $286.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2013-06-30 | $1.55bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2013-06-30 | 136,361,044 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 59,165 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”,

“estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2012 (the “2012 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2012 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2012 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2012 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in four distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition, FMC Minerals and FMC Peroxygens. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. The FMC Health and Nutrition segment focuses on food ingredients that are used to enhance texture, color, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications and ultrapure biopolymers for medical devices. Our FMC Minerals segment manufactures a wide range of inorganic materials including soda ash and lithium. Soda ash is utilized in markets such as glass and detergents and lithium utilized in energy storage, specialty polymers and pharmaceutical synthesis in industrial uses. FMC Peroxygens segment manufactures hydrogen peroxide, specialty peroxygens and silicates. The products in this segment are sought by customers for their specific functionality in markets such as environmental remediation and pulp and paper.

### Second Quarter 2013 Highlights

The following are the more significant developments in our businesses during the three months ended June 30, 2013:

- Revenue of $959.4 million for the three months ended June 30, 2013 increased $54.2 million or six percent versus the same period last year. Revenue increases are associated with sales growth in our FMC Agricultural Solutions and FMC Health and Nutrition segments, partially offset by declines in our FMC Minerals and FMC Peroxygens segment. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in Latin America increased by 16 percent, sales in North America were up seven percent, sales in Asia were up six percent, while sales in Europe, Middle East and Africa declined by seven percent.
- Our gross margin, excluding acquisition/divestiture related charges, increased by approximately $2 million or approximately one percent to $342.9 million versus last year's second quarter driven by higher volumes primarily in our FMC Agricultural Solutions segment partially offset by declines in pricing associated with our FMC Minerals segments - Alkali. Gross margin percent of 36 percent declined from 38 percent, primarily as a result of unfavorable geographic mix of sales in FMC Agricultural Solutions and the aforementioned declines in pricing associated with FMC Minerals - Alkali.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges and acquisition/divestiture related charges, increased by $6.4 million or five percent to $125.6 million. The increase period over period is largely due to increased spending on targeted growth initiatives to meet the growth in our business. The majority of these increases were experienced in our FMC Agricultural Solutions segment.
- Research and Development expenses of $29.1 million increased $0.7 million or two percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $128.9 million increased $2.0 million or two percent primarily due to higher operating results in FMC Agricultural Solutions and a lower effective tax rate. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
- In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. The new segments better reflect the markets where we participate and lead today, and where we expect to grow in the future. We have recast all the data within this filing to reflect the above changes in our reportable segments to conform to the current year presentation. For more information on this presentation change see Note 19 to our condensed consolidated financial statements included within this Form 10-Q.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2013 Revenue | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $442.6 | $393.6 | $937.8 | $847.8 |
| FMC Health and Nutrition | 189.9 | 174.4 | 381.8 | 339.0 |
| FMC Minerals | 244.4 | 249.5 | 469.0 | 485.7 |
| FMC Peroxygens (1) | 83.6 | 87.8 | 163.2 | 173.7 |
| Eliminations | (1.1) | (0.1) | (2.2) | (0.3) |
| Total | $959.4 | $905.2 | $1,949.6 | $1,845.9 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $124.7 | $112.3 | $288.0 | $242.8 |
| FMC Health and Nutrition | 44.3 | 44.9 | 88.0 | 85.7 |
| FMC Minerals | 35.4 | 44.9 | 64.4 | 92.5 |
| FMC Peroxygens | 4.0 | 7.8 | 9.7 | 14.7 |
| Eliminations | (0.1) | 0.1 | (0.2) | 0.1 |
| **Segment operating profit** | 208.3 | 210.0 | $449.9 | $435.8 |
| Corporate and other | (20.3) | (16.9) | (40.1) | (40.4) |
| Operating profit before the items listed below | 188.0 | 193.1 | 409.8 | 395.4 |
| Interest expense, net | (12.3) | (11.5) | (24.0) | (22.8) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income | (6.5) | (5.6) | (16.4) | (7.3) |
| Non-operating pension and postretirement charges (2) | (11.6) | (9.1) | (24.3) | (18.2) |
| Acquisition/divestiture related charges (3) | (1.6) | (3.2) | (1.6) | (6.6) |
| Provision for income taxes | (36.7) | (45.3) | (84.0) | (90.1) |
| Discontinued operations, net of income taxes | 1.9 | (8.1) | (3.3) | (15.5) |
| Net income attributable to noncontrolling interests | (3.2) | (5.4) | (7.3) | (10.9) |
| **Net income attributable to FMC stockholders** | $118.0 | $104.9 | $248.9 | $224.0 |

(1) Commencing with our September 30, 2013 condensed consolidated financial statements to be filed on Form 10-Q, our FMC Peroxygens segment will be classified as a discontinued operation and an asset held for sale. See Note 20 to our condensed consolidated financial statements included within this Form 10-Q for more information.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

(3) Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and costs incurred associated with the potential divestiture of our FMC Peroxygens segment. Charges for the three and six months ended June 30, 2013, represented legal and professional fees directly associated with the potential divestiture of our FMC Peroxygens segment. The charges for three and six month period ended June 30, 2012 relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and charges associated with the potential divestiture of FMC Peroxygens are included in "Selling, general and administrative expenses".

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, acquisition/divestiture related charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2013 | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $118.0 | $104.9 | $248.9 | $224.0 |
| Corporate special charges (income), pre-tax | 19.7 | 17.9 | 42.3 | 32.1 |
| Income tax expense (benefit) on Corporate special charges (income) | (7.6) | (6.4) | (15.8) | (11.7) |
| Corporate special charges (income), net of income taxes | 12.1 | 11.5 | 26.5 | 20.4 |
| Discontinued operations, net of income taxes | (1.9) | 8.1 | 3.3 | 15.5 |
| Tax adjustments | 0.7 | 2.4 | 1.7 | 2.4 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $128.9 | $126.9 | $280.4 | $262.3 |

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition/divestiture related charges, and other income and expense items.

Information about how some of these items relate to our businesses at the segment level is discussed in Note 19 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2012 consolidated financial statements in our 2012 Form 10-K.

In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. The new segments better reflect the markets where we participate and lead today, and where we expect to grow in the future. We have recast all the data within this filing to reflect the above changes in our reportable segments to conform to the current year presentation. For more information on this presentation change see Note 19 to our condensed consolidated financial statements included within this Form 10-Q.

The Segment Results as discussed below for all periods presented have been updated to reflect this presentation change.

### FMC Agricultural Solutions

*($ in Millions)*

| 2013 | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $442.6 | $393.6 | 937.8 | 847.8 |
| Operating Profit | 124.7 | 112.3 | 288.0 | 242.8 |

### Three Months Ended June 30, 2013 vs. 2012

Revenue of $442.6 million increased approximately 12 percent versus the prior year quarter due to sales growth in Latin America, North America, Asia offset by declines in Europe/Middle East/Africa ("EMEA").

Latin America sales of $183.5 million increased 21 percent due primarily to Brazil reflecting volume growth in cotton due to increased planted area and higher herbicide and insecticide sales for soybeans. North America sales of $132.9 million increased 12 percent driven by strong demand for soybean pre-emergent herbicides and growth from new and recently introduced products. Revenue in Asia of $83.7 million increased 24 percent reflecting sales growth in Australia, China, Philippines and Thailand markets. EMEA declined 23 percent to $42.5 million primarily due to unfavorable weather conditions and lower insecticide sales to Africa.

FMC Agricultural Solutions' operating profit of $124.7 million increased approximately 11 percent compared to the year-ago quarter, reflecting the sales growth described in the preceding paragraph, partially offset by unfavorable geographic/product mix. Selling, general and administrative costs were approximately $3 million higher compared to the prior year due to increased spending on growth initiatives and higher people-related costs partially offset by favorable exchange impacts in Brazil.

### Six Months Ended June 30, 2013 vs. 2012

Revenue of $937.8 million increased approximately 11 percent versus the prior year quarter due to sales growth in North America and Asia, partially offset by declines in EMEA and Latin America.

Sales in North America of $359.3 million increased 32 percent driven by strong demand for pre-emergent herbicides and at-plant insecticide as well as growth from new product introductions. Revenue in Asia of $159.1 million increased 14 percent reflecting sales growth in China, Indonesia, Australia and a number of other key countries. EMEA declined 12 percent to $80.1 million primarily due to unfavorable weather conditions and lower insecticide sales. Revenue in Latin America of $339.3 million decreased two percent due mostly to a reduction in planted area for cotton for the 2012/2013 crop season and a slow start in the sugarcane segment in Brazil, partially offset by growth in Argentina and Mexico.

FMC Agricultural Solutions' operating profit of $288.0 million increased approximately 19 percent compared to the year-ago quarter, reflecting the sales growth described in the preceding paragraph, a favorable geographic/product mix and selected price increases. Selling, general and administrative costs were approximately $2 million higher compared to the prior year due to increased spending on growth initiatives partially offset by favorable foreign exchange impacts in Brazil.

In 2013, we expect full-year revenue growth in the high-teens percent reflecting increased volumes due to strong market conditions and growth from new and recently introduced products, including new fungicides, as well as our direct market access initiatives in Asia and Latin America. We expect full-year segment operating profit growth in the mid- to high-teens percent driven by sales gains partially offset by increased SG&A and R&D spending to support growth.

#### Certain Regulatory Issues

In 2009, our bifenthrin product was excluded from the European Commission's official list of approved pesticides. We submitted for reconsideration of that decision and in 2012 bifenthrin was re-approved for use in the European Union. FMC has submitted for registrations in EU Member States. We can resume selling bifenthrin in the European market once the registrations are approved by the Member States. With the exception of France, we expect that most registrations will be approved over the next 24 months; due to the continued inclusion of bifenthrin on the French “Grenelle” list of pesticides we cannot predict when we may regain a French registration. We believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we challenge that decision. In July 2013, the French Conseil d' Etat court dismissed our challenge. During 2013, we will not sell any bifenthrin for agricultural use into the EU, similar to the prior year, and the absence of such sales will not have a material effect on the Company's financial condition or results of operations.

We intend to defend vigorously all our products in the U.S., EU and other countries as our pesticide products are reviewed in the ordinary course of regulatory programs during 2013 as part of the ongoing cycle of re-registration of our pesticide products around the world. In 2008, the Brazilian health surveillance agency informed us that they intend to review carbofuran along with 13 other major pesticides, but has yet to issue any required formal announcement that identifies their specific concerns or preliminary position on re-registration. We are cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to regulatory reviews in Brazil during 2013.

### FMC Health and Nutrition

*($ in Millions)*

| 2013 | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $189.9 | $174.4 | 381.8 | 339.0 |
| Operating Profit | 44.3 | 44.9 | 88.0 | 85.7 |

### Three Months Ended June 30, 2013 vs. 2012

Revenue in FMC Health and Nutrition was $189.9 million, an increase of approximately nine percent versus the prior-year quarter. This increase was due to volume increases of four percent in all core product lines, revenue from acquisitions which increased sales by three percent and favorable pricing which increased sales by two percent. Volume growth was partially attributed to recent capacity expansions.

Segment operating profit of $44.3 million was essentially flat versus the year ago quarter as revenue growth was more than offset by increased raw material costs, higher acquisition related costs and costs to improve our manufacturing capabilities which we refer to as Manufacturing Excellence. Selling, general and administrative costs also increased approximately $1 million compared to the prior year.

### Six Months Ended June 30, 2013 vs. 2012

Revenue in FMC Health and Nutrition was $381.8 million, an increase of approximately 13 percent versus the prior-year quarter. This increase was due to volume increases of seven percent in all core product lines, revenue from acquisitions which increased sales by four percent and favorable pricing which increased sales by two percent. Volume growth was partially attributed to recent capacity expansions.

Segment operating profit of $88.0 million increased by three percent versus the year ago quarter as revenue growth was partially offset by increased raw material costs, acquisition related costs and costs to improve our manufacturing capabilities which we refer to as Manufacturing Excellence. Selling, general and administrative costs also increased approximately $2 million compared to the prior year due to increased spending on growth initiatives.

In 2013, we expect full-year revenue growth of approximately mid-teens percent driven by higher volumes and growth from acquisitions. We expect full-year segment operating profit growth in the low-teens percent, with sales gains in core segment product lines and benefits from the Epax acquisition partially offset by acquisition and manufacturing excellence costs.

### FMC Minerals

*($ in Millions)*

| 2013 | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $244.4 | $249.5 | $469.0 | $485.7 |
| Operating Profit | 35.4 | 44.9 | 64.4 | 92.5 |

### Three Months Ended June 30, 2013 vs. 2012

Revenue in FMC Minerals decreased by approximately two percent versus the prior-year quarter. Revenue decreased due to unfavorable pricing primarily driven by our Alkali division and volume declines in our Lithium division. Partially offsetting these declines were volume gains in Alkali.

Alkali revenues of $193.4 million increased three percent as reduced export pricing, particularly in Asia were more than offset by higher overall volumes.

Lithium revenues of $51.0 million decreased 16 percent compared to the prior year quarter. Lithium experienced reduced volumes which impacted revenue by 19 percent which was partially offset by slightly higher pricing which increased sales by approximately three percent. The lower volumes were due to production constraints, the effects of recent labor disputes in Chilean ports and the impact of snow blocking the Jama Pass between Argentina and Chile which provides critical access to and from Chilean ports.

Segment operating profit of $35.4 million decreased approximately 21 percent versus the year ago quarter. The decrease was primarily driven by lower overall pricing in Alkali and reduced volumes in Lithium.

### Six Months Ended June 30, 2013 vs. 2012

Revenue in FMC Minerals was $469.0 million, a decrease of approximately three percent versus the prior-year quarter primarily due to unfavorable pricing.

Alkali revenues of $373.9 million remained consistent with prior year revenues of $373.4 million, as higher volumes were offset by lower pricing.

Lithium revenues of $95.1 million decreased 15 percent compared to the prior year. Lithium experienced reduced volumes which impacted revenue by 17 percent which was partially offset by slightly higher pricing favorably impacting sales by two percent. The lower volumes were due to production constraints, the effects of recent labor disputes in Chilean ports and the impact of snow blocking the Jama Pass between Argentina and Chile which provides critical access to and from Chilean ports.

Segment operating profit of $64.4 million decreased approximately 30 percent versus the year ago quarter. The decrease is consistent with that of the three months ended June 30, 2013 noted above.

In 2013, we expect full-year revenue growth in the low-single digits percent driven primarily by volumes and higher prices in soda ash in the second half of the year as well as Lithium operation improvements in the second half of 2013. We expect full-year segment operating profit to decline by nearly 20 percent, reflecting Lithium margin improvements offset by more conservative pace of export soda ash price recovery.

### FMC Peroxygens

*($ in Millions)*

| 2013 | Three Months Ended June 30 | 2012 | Six Months Ended June 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $83.6 | $87.8 | $163.2 | $173.7 |
| Operating Profit | 4.0 | 7.8 | 9.7 | 14.7 |

### Three Months Ended June 30, 2013 vs. 2012

Revenue in FMC Peroxygens was $83.6 million, a decrease of approximately five percent versus the prior-year quarter. Revenue decreased due to lower volumes which impacted sales by four percent and unfavorable pricing which reduced sales by one percent. The decrease in volumes was primarily in the persulfate market and the absence of zeolites revenue as a result of our phase out of the zeolites operations in fourth quarter of 2012.

Segment operating profit of $4.0 million decreased approximately 49 percent versus the year ago quarter. The decrease was primarily driven by the revenue declines as well as higher manufacturing costs compared to prior year quarter.

### Six Months Ended June 30, 2013 vs. 2012

Revenue in FMC Peroxygens was $163.2 million, a decrease of approximately six percent versus the prior year. Revenue decrease is primarily due to lower volumes. The decrease in volumes is primarily due to the absence of zeolites revenue as a result of our phase out of the zeolites operations in fourth quarter of 2012 which negatively impacted year to date sales by four percent and reduced volumes in the persulfate market.

Segment operating profit of $9.7 million decreased approximately 34 percent versus the year ago quarter. The decrease was primarily driven by the revenue declines discussed in the preceding paragraph and a mix shift from specialty peroxygens product lines. Higher manufacturing cost as compared to prior year quarter also contributed to the operating profit decline.

Commencing with our September 30, 2013 condensed consolidated financial statements to be filed on Form 10-Q, our FMC Peroxygens segment will be classified as a discontinued operation and an asset held for sale. See Note 20 to our condensed consolidated financial statements included within this Form 10-Q for more information.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on our condensed consolidated statements of income.

### Three Months Ended June 30, 2013 vs. 2012

Corporate and other expenses of $20.3 million in the second quarter of 2013 increased by $3.4 million from $16.9 million in the same period in 2012. The increase period over period is costs to support growth initiatives within our businesses.

### Six Months Ended June 30, 2013 vs. 2012

Corporate and other expenses of $40.1 million in the first half of 2013 decreased slightly from $40.4 million in the same period in 2012.

#### Interest expense, net

### Three Months Ended June 30, 2013 vs. 2012

Interest expense, net for the second quarter of 2013 was $12.3 million as compared to the second quarter of 2012 of $11.5 million.

### Six Months Ended June 30, 2013 vs. 2012

Interest expense, net for the first half of 2013 was $24.0 million as compared to the first half of 2012 of $22.8 million. The increased interest expense period-over-period is due to the increase in total outstanding debt during the first half of 2013 compared to the comparable period in 2012.

#### Corporate special (charges) income

### Three Months Ended June 30, 2013 vs. 2012

#### Restructuring and other charges (income)

These charges totaled $6.5 million in the second quarter of 2013 compared to $5.6 million in the second quarter of 2012. Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income). See the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Restructuring and asset disposal charges in 2013 of $4.4 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $2.1 million included environmental charges associated with remediation at continuing operating sites.

Restructuring and asset disposal charges in 2012 of $4.3 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $1.3 million were primarily associated with charges for environmental remediation at operating sites.

The liabilities associated with the restructuring charges listed above are also included within Note 7 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended June 30, 2013 was $11.6 million compared to $9.1 million for the three months ended June 30, 2012. The increase in charges was primarily the result of higher amortization impacts of actuarial losses of $4.3 million. These expenses are included as a component of the line item "Selling, general and administrative expenses" on our condensed consolidated statements of income.

#### Acquisition/divestiture related charges

Charges of $1.6 million for the three months ended June 30, 2013, represented legal and professional fees directly associated with the potential divestiture of our FMC Peroxygens segment. There were no acquisition-related charges for the three months ended June 30, 2013. Charges for the three months ended June 30, 2012 related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with acquisitions completed prior to 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and charges associated with the potential divestiture our FMC Peroxygens are included in "Selling, general and administrative expenses".

### Six Months Ended June 30, 2013 vs. 2012

#### Restructuring and other charges (income)

These charges totaled $16.4 million in the first half of 2013 compared to $7.3 million in 2012. Restructuring and asset disposal charges in 2013 of $12.8 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $3.6 million were primarily associated with environmental charges associated with remediation at continuing operating sites.

Restructuring and asset disposal charges in 2012 of $5.4 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $1.9 million were primarily associated with charges for environmental remediation at operating sites.

#### Non-operating pension and postretirement charges

The charge for the six months ended June 30, 2013 was $24.3 million compared to $18.2 million for the six months ended June 30, 2012. The increase in charges was primarily the result of higher amortization impacts of actuarial losses of $8.7 million.

#### Acquisition/divestiture related charges

Charges for the six months ended June 30, 2013 of $1.6 million, represented legal and professional fees directly associated with the potential divestiture of our FMC Peroxygens segment. There were no acquisition-related charges for the six months ended June 30, 2013. Charges for the six months ended June 30, 2012 of $6.6 million related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with acquisitions completed prior to 2012.

#### Provision for income taxes

### Three Months Ended June 30, 2013 vs. 2012

Provision for income taxes was $36.7 million resulting in an effective tax rate of 23.5 percent compared to expense of $45.3 million resulting in an effective tax rate of 27.7 percent for the three months ended June 30, 2013 and 2012, respectively. The decrease in the effective tax rate was primarily the result of the change in the mix of domestic income compared to income earned outside of the U.S. A larger portion of our earnings were earned by our foreign operations which have lower tax rates than the U.S.

### Six Months Ended June 30, 2013 vs. 2012

Provision for income taxes was $84.0 million resulting in an effective tax rate of 24.5 percent compared to expense of $90.1 million resulting in an effective tax rate of 26.5 percent for the six months ended June 30, 2013 and 2012, respectively. The decrease in the effective tax rate was consistent with the change in the three months ended June 30, 2013, as discussed in the previous paragraph.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued prior to 2002. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Commencing with our September 30, 2013 condensed consolidated financial statements to be filed on Form 10-Q, our FMC Peroxygens segment will be classified as a discontinued operation and an asset held for sale. See Note 20 to our condensed consolidated financial statements included within this Form 10-Q for more information.

### Three Months Ended June 30, 2013 vs. 2012

Discontinued operations, net of income taxes totaled a gain of $1.9 million for the three months ended June 30, 2013, compared to a charge of $8.1 million for the three months ended June 30, 2012. Discontinued operations for the three months ended June 30, 2013, includes a gain of $13.9 million associated with an insurance recovery related to previously discontinued operations legal matters which did not occur in 2012. This gain was partially offset by provisions for environmental liabilities and legal reserves and expenses related to previously discontinued operations. The charge for the three months ended June 30, 2012 represented increases to legal reserves and expenses and maintenance activities for a number of environmental sites related to discontinued operations.

### Six Months Ended June 30, 2013 vs. 2012

Discontinued operations, net of income taxes totaled a charge of $3.3 million for the six months ended June 30, 2013, compared to a charge of $15.5 million for the six months ended June 30, 2012. The charges for the six months ended June 30, 2013 and 2012, were primarily related to charges for legal reserves and expenses related to discontinued operations and an increase in our reserves for operating and maintenance activities for a number of environmental sites. The decrease in 2013 was a result of the gain associated with an insurance recovery discussed in the preceding paragraph.

#### Net income attributable to FMC stockholders

### Three Months Ended June 30, 2013 vs. 2012

Net income attributable to FMC stockholders increased to $118.0 million for the three months ended June 30, 2013, from $104.9 million for the three months ended June 30, 2012. The increase was primarily due to higher operating profits in FMC Agricultural Solutions, the gain recognized in discontinued operations and a lower effective tax rate. Partially offsetting the aforementioned increases were a decreased in FMC Minerals' operating profits and an increase in restructuring and other charges and non-operating pension and postretirement charges.

### Six Months Ended June 30, 2013 vs. 2012

Net income attributable to FMC stockholders increased to $248.9 million for the six months ended June 30, 2013, from $224.0 million for the six months ended June 30, 2012. The increase was primarily due to higher operating profits in FMC Agricultural Solutions, partially offset by the decrease in FMC Minerals' operating profits and an increase in restructuring and other charges and non-operating pension and postretirement charges.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at June 30, 2013 and December 31, 2012, were $77.4 million and $77.1 million, respectively. Of the cash and cash equivalents balance at June 30, 2013, $66.0 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings. In the event that funds from our foreign subsidiaries are repatriated to the U.S., we would be required to accrue and pay U.S. taxes on those amounts.

In June 2013, we commenced a $1.5 billion commercial paper program supported by our 2011 Credit Agreement. This program allows the Company to borrow at rates generally more favorable that those available under our 2011 Credit Agreement. The Company has used proceeds from the commercial paper program for general corporate purposes. At June 30, 2013, the average effective interest rate on these borrowings was 0.3%.

At June 30, 2013, we had total debt of $1,070.6 million as compared to $965.1 million at December 31, 2012. The increase was primarily associated with higher borrowings under our commercial paper program to support working capital requirements. Total debt included $762.4 million and $908.8 million of long-term debt (excluding current portions of $21.8 million and $5.7 million) at June 30, 2013 and December 31, 2012, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, increased from $50.6 million at December 31, 2012 to $286.4 million at June 30, 2013.

### Statement of Cash Flows

*Cash provided (required) by operating activities was $245.3 million and $267.9 million for the six months ended June 30, 2013 and 2012, respectively.*

The table below presents the components of net cash provided (required) by operating activities.

*(in Millions)*

| 2013 | Six Months Ended June 30 | 2012 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $367.2 | $363.5 |
| Significant non-cash expenses (1) | 115.6 | 108.1 |
| **Operating income before non-cash expenses (Non-GAAP)** | **482.8** | **471.6** |
| Change in trade receivables (2) | 27.2 | (64.1) |
| Change in inventories (3) | 9.0 | (90.7) |
| Change in accounts payable (4) | (74.4) | (16.1) |
| Change in accrued rebates (5) | 178.7 | 142.9 |
| Change in advance payments from customers (6) | (135.1) | (71.4) |
| Change in all other operating assets and liabilities (7) | (69.6) | (21.7) |
| Restructuring and other spending (8) | (9.2) | (5.4) |
| Environmental spending, continuing, net of recoveries (9) | (2.9) | (2.3) |
| Pension and other postretirement benefit contributions (10) | (43.0) | (33.2) |
| **Cash basis operating income (Non-GAAP)** | **363.5** | **309.6** |
| Interest payments | (22.4) | (13.5) |
| Tax payments | (89.5) | (22.0) |
| Excess tax benefits from share-based compensation | (6.3) | (6.2) |
| **Cash provided (required) by operating activities** | **$245.3** | **$267.9** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) Improved trade receivable collections resulted in a cash addition due primarily to reduced collection time particularly in FMC Agricultural Solutions. Amounts for both periods also include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.

(3) The change in inventory from 2012 to 2013 was due to timing of inventory build in our FMC Agricultural Solutions segment to satisfy 2013 season demand. The majority of the build to satisfy the 2013 demand occurred in the fourth quarter of 2012. Higher sales also contributed to the change year over year.

(4) The use of cash in our accounts payable balance was driven by the Q4 2012 inventory build to satisfy 2013 demand, which was paid during the first quarter 2013.

(5) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year. The increase from 2012 to 2013 is primarily associated with the increased sales for FMC Agricultural Solutions in North America.

(6) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. The use of cash for each year presented is consistent with our sales increases year over each year. We received substantial increases in advance payments from customers at the end of 2012 related to 2013 season compared to the prior period.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities.

(8) See Note 7 in our condensed consolidated financial statements included in this Form 10-Q for further details.

(9) Included in our income for both periods presented are environmental charges of $2.0 million, respectively, for environmental remediation at our operating sites. The amounts in 2013 will be spent in periods beyond first quarter 2013. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) Amounts include voluntary contributions to our U.S. defined benefit plan of $27.0 million and $28.0 million, respectively.

*Cash required by operating activities of discontinued operations was $12.2 million and $20.9 million for the six months ended June 30, 2013 and 2012, respectively.*

This change was primarily due a $13.9 million insurance recovery received during the second quarter of 2013, which did not occur in 2012. This recovery partially offset higher environmental spending related to discontinued operations during the six months ended June 30, 2013, compared to the prior year period.

*Cash required by investing activities was $112.7 million and $199.0 million for the six months ended June 30, 2013 and 2012, respectively.*

The decrease in spending during the six months ended June 30, 2013, as compared to the same period in 2012 was primarily due to acquisitions completed during the first half of 2012 whereas no acquisitions were completed during the first six months of 2013.

*Cash required by financing activities was $119.1 million and $130.9 million for the six months ended June 30, 2013 and 2012, respectively.*

The decrease in cash required by financing activities is primarily due to borrowings under our commercial paper program which was implemented during the second quarter of 2013 and fewer repurchases of our common stock under our publicly announced program. See further discussion on these repurchases below under the section “Other potential liquidity needs”. Partially offsetting these two items were repayments of borrowings under our committed credit facility, the acquisition of an additional 6.25% ownership interest in our consolidated entity FMC Wyoming and higher dividends paid compared to 2012. See Note 13 in our condensed consolidated financial statements included in this Form 10-Q for further details on the acquisition of additional ownership interest in FMC Wyoming.

### Other potential liquidity needs

Our cash needs for 2013 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At June 30, 2013 our remaining borrowing capacity under our revolving credit facility was $1,163 million (which include borrowings under our commercial paper program).

As discussed further in Note 20 to the condensed consolidated financial statements included within this Form 10-Q, we completed an acquisition in July 2013 for approximately $345 million.

Projected 2013 capital expenditures as well as expenditures related to contract manufacturers are expected to be approximately 30 percent higher than 2012 levels, primarily to increase capacity in our FMC Health and Nutrition and FMC Minerals segments.

Projected 2013 spending includes approximately $40 million of net environmental remediation spending. This spending does not include expected spending of approximately $10 million associated with capital projects relating to environmental control facilities. Also, we expect to spend approximately $30 million in 2013 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through June 30, 2013 of $27.0 million and expect to make approximately $40 million in voluntary contributions throughout 2013. These contributions are in excess of the minimum requirements. We made voluntary contributions of $65 million in 2012. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the six months ended June 30, 2013 and 2012, we paid $37.1 million and $22.9 million, respectively, in dividends declared in previous periods. On July 18, 2013, we paid dividends totaling $18.5 million to our shareholders of record as of June 28, 2013. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of June 30, 2013.

On April 23, 2013 our Board-authorized the repurchase of up to $500 million of our common shares. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. The authorization of April 23, 2013, replaced the previous authority under which $134.9 million was unused.

During the six months ended June 30, 2013, we repurchased 1,843,200 shares under the publicly announced repurchase program for $109.9 million. At June 30, 2013, $500 million remained unused under our Board-authorized repurchase program.

The Company has entered into an accelerated share repurchase agreement (ASR) under which it will repurchase approximately $250 million of its common shares, with an initial delivery of approximately 3.2 million shares expected to occur by July 31, 2013. The shares will be acquired under the Company's previously announced $500 million share repurchase program. Final settlement of the ASR is expected to be completed by year end, but may be completed sooner under certain circumstances. The final number of shares that the company is repurchasing under the ASR, the timing of the final settlement, and the aggregate cost will depend upon prevailing market conditions, the final discounted volume-weighted average share price over the term of the ASR, and other customary adjustments.

The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") was signed into law in 2010. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe they will not adversely affect our liquidity in a material way.

### Commitments and Contingencies

See Note 18 to our condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2012 can be found in a table included within Part II, Item 7 of our 2012 consolidated financial statements on our 2012 Form 10-K. There have been no significant changes to our contractual commitments during the six months ended June 30, 2013.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2012 consolidated financial statements on our 2012 10-K. There have been no material changes related to climate change from the information reported in our 2012 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 17 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At June 30, 2013, our financial instrument position was a net asset of $0.6 million compared to a net liability of $2.2 million at December 31, 2012. The change in the net financial instrument position was primarily due to larger unrealized gains in our commodity and foreign exchange portfolios.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are approximately seven percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at June 30, 2013 and December 31, 2012, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in an decrease in the net liability position of $3.8 million at June 30, 2013, compared to a $4.6 million decrease of the net liability position at December 31, 2012. A 10 percent decrease in energy market prices would result in a increase of $3.8 million in the net liability position at June 30, 2013, compared to an increase of $4.1 million of the net liability position at December 31, 2012.

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of June 30, 2013 and December 31, 2012 our net financial instrument position was immaterial.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at June 30, 2013 and December 31, 2012, with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in an increase of $1.6 million in the net asset position at June 30, 2013, compared to a decrease of $5.5 million in the net liability position at December 31, 2012. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in a decrease of $1.9 million in the net asset position at June 30, 2013, compared to a increase of $4.3 million in the net liability position at December 31, 2012. As a result, at June 30, 2013 the net asset position would have become a net liability.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of June 30, 2013 and December 31, 2012, we had no interest rate swap agreements.

Our debt portfolio, at June 30, 2013, is composed of 71 percent fixed-rate debt and 29 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2011 credit agreement, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at June 30, 2013, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $1.5 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $0.6 million for the first six months of 2013.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,477 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2013, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended June 30, 2013, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of June 30, 2013, the related condensed consolidated statements of income and comprehensive income for the three-month and six-month periods ended June 30, 2013 and 2012, and the related condensed consolidated statements of cash flows for the six-month periods ended June 30, 2013 and 2012. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2012, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 19, 2013, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2012, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

July 30, 2013

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2012 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed Jul 30, 2013.
Source: SEC EDGAR, the filing index for accession 0000037785-13-000032. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
